POPULARITY
Categories
30 episodes with Tract
44 episodes with Tract
20 episodes with Tract
35 episodes with Tract
7 episodes with Tract
16 episodes with Tract
5 episodes with Tract
12 episodes with Tract
4 episodes with Tract
5 episodes with Tract
7 episodes with Tract
3 episodes with Tract
5 episodes with Tract
3 episodes with Tract
4 episodes with Tract
82 episodes with Tract
5 episodes with Tract
8 episodes with Tract
5 episodes with Tract
8 episodes with Tract
3 episodes with Tract
3 episodes with Tract
4 episodes with Tract
6 episodes with Tract
4 episodes with Tract
3 episodes with Tract
2 episodes with Tract
3 episodes with Tract
3 episodes with Tract
3 episodes with Tract
2 episodes with Tract
4 episodes with Tract
8 episodes with Tract
2 episodes with Tract
2 episodes with Tract
4 episodes with Tract
Located in the heart of Clear Brook, Virginia, Russell Ridge Farm Market is more than just a new addition to the region's agritourism scene—it's a testament to family legacy, community spirit, and the power of reinvention. In this episode of “The Valley Today,” host Janet Michael, joined by Winchester-Frederick County Tourism's Justin Kerns, sits down with Travis Russell to uncover the remarkable journey behind this burgeoning family farm market. A Family Affair Born of Adversity The story of Russell Ridge Farm Market is rooted in resilience. As Travis recounts, the Russell family has been farming in Clear Brook for three generations, primarily focusing on row crops like corn, soybeans, and wheat. But when a severe drought struck just after the family acquired a new property in 2023, the Russells faced a pivotal moment. “We were in the garage one evening, wondering what we were going to do,” Travis recalls. The answer? Embrace agritourism and open their land to the community. What began as a last-minute idea—cutting a corn maze into a field that wouldn't yield a profitable crop—quickly blossomed into a local sensation. The community rallied, and the Russells realized they had tapped into a growing desire for authentic, family-friendly farm experiences. Building a Community Hub Now entering its second season, Russell Ridge Farm Market has expanded both its offerings and its ambitions. The new barn, a labor of love still under construction, will soon house not only the market's homemade goods and crafts but also a dedicated event space for birthday parties, showers, and corporate gatherings. The market's focus remains on creating a welcoming environment for families, with attractions like a meticulously planned corn maze, hayrides, a pedal tractor track, and an ever-evolving playground. Travis emphasizes the importance of providing children with the kind of outdoor, hands-on experiences he cherished growing up—something increasingly rare in today's world. “It's so exciting to watch kids have the time of their life running around on a playground and through the corn maze,” he says. Events like the annual corn maze race, pumpkin painting, and the wildly popular “Tract or Treat” (a farm-themed twist on trunk-or-treat) have become community favorites. Collaboration Over Competition One of the most striking themes of the conversation is the spirit of collaboration among local farmers. Rather than competing, area farm markets support each other—sharing advice, produce, and even event ideas. “You'd think it would be really competitive, but it's not,” Justin notes. “The more you have, the more people come.” This camaraderie extends to sourcing local goods, with the Russells selling apples and pumpkins from neighboring farms and offering a range of homemade treats, crafts, and family recipes. Preserving Farmland, Preserving Heritage Beyond the fun and festivities, Russell Ridge Farm Market represents a deeper mission: preserving farmland in the face of development. As Travis and Justin discuss, once farmland is lost to housing, it rarely returns. By diversifying into agritourism, the Russells are not only sustaining their own family's legacy but also contributing to the broader effort to keep rural spaces alive for future generations. A Place Where Everyone Belongs The conversation is peppered with personal anecdotes—Janet's family ties to the Russells, memories of chocolate pies at holiday dinners, and the small-town quirks of sharing a last name with half the county. These stories underscore the market's role as a gathering place, where neighbors become friends and traditions are both honored and created anew. Plan Your Visit Russell Ridge Farm Market is open Saturdays and Sundays through the end of October, with special Friday night events like the Moonlit Hay Ride and Flashlight Corn Maze. Admission is $10 (kids two and under are free), covering unlimited access to all attractions. The market accepts both cash and credit, and there's plenty of parking for visitors. For more information, follow Russell Ridge Farm Market on Facebook and Instagram. Russell Ridge Farm Market is more than a response to a tough year—it's a celebration of family, community, and the enduring value of local agriculture. As Travis puts it, “My goal is to keep something on the farm for generations to come.” Thanks to the Russells' vision and the community's support, that future looks bright indeed. Visit the Winchester-Frederick County tourism website for a full calendar of local farm markets and events.
In an age defined by radical individualism, democratic consensus, and widespread institutional distrust, the concept of apostolic succession presents a profound challenge to modern sensibilities. Bishop Kevin considers new models for a new time
Due to a glitch inthe system the closing prayer for the Pod Tract is found in this post
In this episode of the Hunting Gear Podcast, host Dan Johnson speaks with John LaCorte from Tract Optics about preparing for the hunting season, overcoming personal challenges in archery, and the evolution of Track Optics as a direct-to-consumer brand. They discuss the importance of product quality, customer feedback, and the expansion of their product lines, including spotting scopes and the Impact Ballistics Program. The conversation emphasizes the brand's commitment to providing high-quality optics at competitive prices while maintaining strong customer engagement.takeaways John LaCorte is excited for the upcoming hunting season after overcoming a serious injury. The psychological impact of not being able to bow hunt can be significant. Track Optics focuses on providing value by cutting out the middleman. The company has not raised prices despite industry challenges like tariffs. Customer feedback directly influences product development at Track Optics. The demand for higher magnification scopes is increasing among older hunters. Track Optics offers a lifetime warranty on all products. The Impact Ballistics Program helps users understand their reticle and bullet drop. Quality control is a priority, with attention to detail in every product. Direct communication with customers is a key aspect of Track Optics' business model. Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode of the Hunting Gear Podcast, host Dan Johnson speaks with John LaCorte from Tract Optics about preparing for the hunting season, overcoming personal challenges in archery, and the evolution of Track Optics as a direct-to-consumer brand. They discuss the importance of product quality, customer feedback, and the expansion of their product lines, including spotting scopes and the Impact Ballistics Program. The conversation emphasizes the brand's commitment to providing high-quality optics at competitive prices while maintaining strong customer engagement.takeawaysJohn LaCorte is excited for the upcoming hunting season after overcoming a serious injury.The psychological impact of not being able to bow hunt can be significant.Track Optics focuses on providing value by cutting out the middleman.The company has not raised prices despite industry challenges like tariffs.Customer feedback directly influences product development at Track Optics.The demand for higher magnification scopes is increasing among older hunters.Track Optics offers a lifetime warranty on all products.The Impact Ballistics Program helps users understand their reticle and bullet drop.Quality control is a priority, with attention to detail in every product.Direct communication with customers is a key aspect of Track Optics' business model.
In this episode of the Hunting Gear Podcast, host Dan Johnson speaks with John LaCorte from Tract Optics about preparing for the hunting season, overcoming personal challenges in archery, and the evolution of Track Optics as a direct-to-consumer brand. They discuss the importance of product quality, customer feedback, and the expansion of their product lines, including spotting scopes and the Impact Ballistics Program. The conversation emphasizes the brand's commitment to providing high-quality optics at competitive prices while maintaining strong customer engagement.takeaways John LaCorte is excited for the upcoming hunting season after overcoming a serious injury. The psychological impact of not being able to bow hunt can be significant. Track Optics focuses on providing value by cutting out the middleman. The company has not raised prices despite industry challenges like tariffs. Customer feedback directly influences product development at Track Optics. The demand for higher magnification scopes is increasing among older hunters. Track Optics offers a lifetime warranty on all products. The Impact Ballistics Program helps users understand their reticle and bullet drop. Quality control is a priority, with attention to detail in every product. Direct communication with customers is a key aspect of Track Optics' business model. Learn more about your ad choices. Visit megaphone.fm/adchoices
Where would you take refuge in a bad storm? Some people went to the wrong place? Would you also go there? It had a foundation of sandstone, and was no match for the storm. What is your foundation for eternity?
Send us a textBiliary Tract Cancers - Cholangiocarcinomas and Gallbladder cancers are often seen as rare and aggressive cancers.
Jeff Smith and Carson Odegard sit down with waterfowl historian Yancey Forest-Knowles to unpack the Sacramento–San Joaquin Delta—its island clubs, levees and tides, and the public access that still lets you chase mallards and specks on big water today.What you'll hearHow the Delta was built — from early private island claims and hand-built levees to today's twin pressures of saltwater intrusion and export pumping.Club lore & big names — Twitchell Island's first club (1880), Venice and Mandeville's eras, and the “Mallard Hole” stories tied to Barron Hilton and Hollywood guests.Flood risk is real — why peat islands subside and how Jones Tract's 2004 failure floated a clubhouse away.Public opportunity — boat-in spots and state-permitted floating blinds at Frank's Tract (plus Big Break, Stone Lakes, Decker & more), and the on-water etiquette that keeps it working.Access rules that matter — anchor next to levees to hunt, but don't set foot on them.Today's mix of ag & restoration — CWA ownership on Quimby and habitat work across Medford, Sherman, and sister islands.From 19th-century market hunts to modern floating blinds, this one maps the Delta's history and gives practical pointers for anyone looking to do it right on big water.
Featuring perspectives from Dr Haley Ellis and Dr James J Harding, including the following topics: Introduction: Is Biliary Tract Cancer (BTC) the New Non-Small Cell Lung Cancer? … Why? (0:00) Case: A woman in her mid 70s with metastatic cholangiocarcinoma receives first-line gemcitabine/cisplatin with durvalumab — Warren S Brenner, MD (8:42) Case: A man in his late 70s with metastatic biliary cancer (HER2 IHC 2+) discontinues first-line chemotherapy/immunotherapy because of exacerbation of Crohn's disease — Neil Morganstein, MD (17:48) Case: A man in his early 70s with metastatic cholangiocarcinoma (FGFR2 rearrangement) receives gemcitabine/oxaliplatin with durvalumab and experiences a rapid clinical decline — Kimberly Ku, MD (27:14) Case: A woman in her late 40s with Stage IV recurrent cholangiocarcinoma (FGFR2 rearrangement) receives pemigatinib — Justin Peter Favaro, MD, PhD (40:15) Case: A woman in her early 60s with HER2-positive cholangiocarcinoma develops metastatic disease during adjuvant capecitabine therapy — Dr Morganstein (46:09) CME information and select publications
Dr Haley Ellis and Dr James J Harding review actual patient cases and summarize clinical trial findings regarding the treatment of biliary tract cancers. CME information and select publications here.
Dr Haley Ellis and Dr James J Harding review actual patient cases and summarize clinical trial findings regarding the treatment of biliary tract cancers. CME information and select publications here.
Dr Haley Ellis and Dr James J Harding review actual patient cases and summarize clinical trial findings regarding the treatment of biliary tract cancers. CME information and select publications here.
Lorenza Rimassa, MD - Shifting the Paradigm in Biliary Tract Cancers: Contemporary Data and Decision-Making
Lorenza Rimassa, MD - Shifting the Paradigm in Biliary Tract Cancers: Contemporary Data and Decision-Making
Lorenza Rimassa, MD - Shifting the Paradigm in Biliary Tract Cancers: Contemporary Data and Decision-Making
Lorenza Rimassa, MD - Shifting the Paradigm in Biliary Tract Cancers: Contemporary Data and Decision-Making
Lorenza Rimassa, MD - Shifting the Paradigm in Biliary Tract Cancers: Contemporary Data and Decision-Making
Lorenza Rimassa, MD - Shifting the Paradigm in Biliary Tract Cancers: Contemporary Data and Decision-Making
On a scale of five stars, how sure are you of going to heaven? If you cannot choose five stars, then you need to read this gospel tract.
Energetic Health Institute Radio with Angela Bulaga CHN – Brain fog, fatigue, GI issues (gas, bloating, nausea, vomiting, constipation, diarrhea). Oral thrush (white patches in the mouth and throat, soreness, and in the corners of the mouth), vaginal yeast infections (itching, burning, and discharge), jock itch, and anal itching. Athletes' foot, skin rashes (Eczema; Red, moist, or scaly rash, sometimes in...
Energetic Health Institute Radio with Angela Bulaga CHN – Brain fog, fatigue, GI issues (gas, bloating, nausea, vomiting, constipation, diarrhea). Oral thrush (white patches in the mouth and throat, soreness, and in the corners of the mouth), vaginal yeast infections (itching, burning, and discharge), jock itch, and anal itching. Athletes' foot, skin rashes (Eczema; Red, moist, or scaly rash, sometimes in...
Should a Christian get body piercings? Pierced ears? Pierced nose? Pierced eyebrows? Pierced tongue? Pierced lips? Pierced cheeks? Other piercings? Does the Bible even address this subject? Yes it does.
In today's episode, we had the opportunity to speak with Arndt Vogel, MD, about the European Commission's (EC's) July 2025 marketing authorization of zanidatamab-hrii (Ziihera) for the treatment of adult patients with previously treated, unresectable, locally advanced or metastatic HER2-positive biliary tract cancer. Dr Vogel is a faculty member at the University of Toronto Institute of Medical Science, a scientist at the Toronto General Hospital Research Institute, and a medical oncologist at the UHN–Princess Margaret Cancer Centre in Canada. In our exclusive interview, Dr Vogel highlighted the clinical importance of this decision, emphasizing that it represents a significant advancement for a molecularly defined subgroup of patients with limited treatment options and historically poor outcomes. He explained that biliary tract cancers, including cholangiocarcinoma, are associated with high recurrence rates and poor survival, even in patients who undergo curative-intent surgery. For patients in the advanced setting, second-line chemotherapy offers modest clinical benefit, with objective response rates of approximately 6%, a median progression-free survival of approximately 3 months, and a median overall survival of approximately 12 months. Vogel discussed the data supporting the EC's approval, which was based on findings from the phase 2b HERIZON-BTC-01 trial (NCT04466891)—the largest study conducted to date evaluating HER2-directed therapy in this patient population. In the trial, at a median follow-up of 21.9 months, patients with centrally confirmed HER2-positive tumors (n = 80) who received zanidatamab achieved a confirmed objective response rate (cORR) of 41.3% (95% CI, 30.4-52.8). The median duration of response was 14.9 months (95% CI, 7.4-not reached), and the median overall survival reached 15.5 months (95% CI, 10.4-18.5).
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.
PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will be available until June 29, 2026.Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy & Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent medical education grants from Incyte Corporation, Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.
Biliary tract cancer (BTC) presents a complex puzzle for the interprofessional healthcare team. With its diverse subtypes and unique molecular features, diagnosis and treatment require a personalized approach. Stay ahead of the curve with insights from leading experts, Dr. Anjana Pillai and Dr. Rachna Shroff, as they explore the latest genomic research, targeted therapies, and emerging treatment strategies in this dynamic podcast. Listen now to hear the Multidisciplinary Task Force perspective and strategies to optimize patient care in this rapidly evolving landscape. Click here to claim your credit for this podcast:
With so many treatment modalities for upper tract urothelial carcinoma, how does new evidence inform optimal care? In this episode of BackTable Tumor Board, urologic oncologist Dr. Nirmish Singla (Johns Hopkins), medical oncologist Dr. Jeannie Hoffman-Censits (Johns Hopkins), and urologic oncologist Dr. Bogdana Schmidt discuss treatment and diagnosis of upper tract urothelial carcinoma (UTUC). --- This podcast is supported by: Ferring Pharmaceuticalshttps://ad.doubleclick.net/ddm/trackclk/N2165306.5658203BACKTABLE/B33008413.420220578;dc_trk_aid=612466359;dc_trk_cid=234162109;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;gdpr=${GDPR};gdpr_consent=${GDPR_CONSENT_755};gpp=${GPP_STRING_755};gpp_sid=${GPP_SID};ltd=;dc_tdv=1 --- SYNPOSIS The discussion covers real-world UTUC cases, highlighting diagnostic challenges, treatment options, and evidence-based management strategies. They address scenarios ranging from localized to advanced UTUC, the role of systemic therapies, perioperative treatments, and the potential for novel approaches with immune checkpoint inhibitors. The episode underscores the evolving landscape of UTUC treatment and the importance of clinical trials and emerging biomarkers in improving patient outcomes. --- TIMESTAMPS 00:00 - Introduction 02:49 - Case Study 1: 66-Year-Old Male with UTUC11:19 - Case Study 2: 73-Year-Old Male with High-Grade Urothelial Carcinoma28:11 - Intravesical Chemotherapy Protocols30:44 - Case Study 3: 57-Year-Old Male with Recurrent Urothelial Cancer41:25 Clinical Trials and Emerging Treatments45:40 Case Study: 55-Year-Old Female with Bulky Lymphadenopathy 56:45 Concluding Remarks and Future Directions --- RESOURCES Society of Urologic Oncologyhttps://suonet.org/home.aspx
In this episode, we review the high-yield topic of Gastrointestinal Tract Histology from the Gastrointestinal section.Follow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets
On this episode of the podcast the grid makes the travel across the pond to Italy for the FORMULA 1 AWS GRAN PREMIO DEL MADE IN ITALY E DELL'EMILIA-ROMAGNA 2025 (say that 10 times fast). Tract prixview, gambling predictions, and Italian fun facts. Enjoy!
Hi, I'm John Sorensen, President of Evangelism Explosion International, and you're listening to Share Life Today. If you've seen someone leave a Gospel tract in a restaurant or hand one to a stranger walking by, have you ever thought, “I wonder if they'll read it?” I'd like to suggest that our first and best response should be to ask the Holy Spirit to compel the person to read it as He did with Philip. Philip was sitting on a park bench talking on his phone when someone walked by and handed him a Gospel tract. The Holy Spirit prompted Philip to open it. So he did, and he read the whole thing. Romans 3:23 jumped off the page, “For the wages of sin is death, but the gift of God is eternal life through Christ Jesus our Lord.” Philip was convicted, and he repented. Now, it just so happened that he read EE's Do You Know For Sure? tract. Philip has since ordered them and started a tract ministry. For a free online Gospel tract you can use wherever you go plus other resources and tips for sharing your faith, visit our website at sharelife.today.
Hi, I'm John Sorensen, President of Evangelism Explosion International, and you're listening to Share Life Today. Should we still use tracts for evangelism? As I walked toward the meeting hall at a conference, I saw one of the security guards sitting and reading our “Do You Know For Sure” tract. I went over and asked him, “Do you understand what you're reading?” And he said, “How can I unless someone explains it to me?” Immediately, I thought of the story of the Ethiopian eunuch when he met Philip on the road to Gaza. And just like the Bible story, this security guard listened carefully to the Gospel and gave his heart to Jesus Christ right there. And recently, we held a workshop to teach Christians how to share their faith, which they went out and did that very day! A few days later, a man called to tell us that he had made a decision to put his trust in Jesus through a tract that a team left with him. Tracts can be a great tool for us use to share our faith. For more information on how you can share your faith, visit our website at sharelife.today.
Welcome to the emDOCs.net podcast! Join us as we review our high-yield posts from our website emDOCs.net.Today on the emDOCs cast with Rachel Bridwell, MD, and Brit Long, MD (@long_brit), we cover left ventricular outflow tract obstruction, or LVOTO. To continue to make this a worthwhile podcast for you to listen to, we appreciate any feedback and comments you may have for us. Please let us know!Subscribe to the podcast on one of the many platforms below:Apple iTunesSpotifyGoogle Play
Hi, I'm John Sorensen, President of Evangelism Explosion International, and you're listening to Share Life Today. You know, it's unthinkable. It's February 1975, in Fort Lauderdale, Florida. You leave a Gospel tract with a young gas station attendant you come across while you're filling your tank. He takes the tract, shoves you, gives you an earful; and while you're stammering for words, he walks away. Now, if you're someone who likes to hand out Gospel tracts, you've probably never had an experience quite like that, but I'll bet you've still wondered if the people you give these tracts to actually read them or they toss them. Hey, we all have. In fact, some people will argue that Gospel tracts simply don't work. But let's get back to the young gas station attendant. His name is Jeff, and forty years later, he reaches out to us to find the person who gave him that Gospel tract. Through it, he accepted Jesus as His Savior, and his life was forever changed. For a free online Gospel tract you can use wherever you go, visit our website at sharelife.today.
WUPF || UMPJ || The year 2025 session of World University of Prayer and Fasting Course for CEMAC Zone and Nigeria in Ndoumbi. From 30th April to 7th of May 2025
TAKEAWAYSAre you an active follower of Christ or just a Sunday morning believer? Your children are watchingYou get to choose what your kids are going to be exposed toYou can't completely isolate your children from culture; you have to prepare them to serve in it somehowNo matter how old or how young you are, God hears your prayersChildren can absolutely lead people to Christ just as well as adults can
Welcome to another episode of the Oncology Brothers podcast! In this episode, Drs. Rohit and Rahul Gosain, both practicing community medical oncologists, continue their discussion on HER2-positive biliary tract cancer. They are joined by Dr. Shubham Pant from MD Anderson, who shares his expertise on this rapidly evolving field. In this episode, we cover: • The importance of HER2 testing in biliary tract cancers, including intrahepatic and extrahepatic cholangiocarcinomas and gallbladder cancers. • Who should be tested for HER2 positivity and how to classify HER2-positive disease. • The role of next-generation sequencing (NGS) and immunohistochemistry (IHC) in determining HER2 status. • Current treatment options for HER2-positive biliary tract cancer, including the latest clinical trials and approved therapies like trastuzumab deruxtecan and zanidatamab. • The significance of patient-centered decision-making and managing side effects associated with these treatments. • Insights into the potential for brain metastases in biliary tract cancer and the importance of ongoing surveillance. Join us as we delve into the latest data and strategies for managing HER2-positive biliary tract cancer, and stay tuned for our next episode where we will discuss side effects and management of these therapies. Accreditation/Credit Designation Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource®, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Commercial Support This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc. Link to gain CME credits from this activity: https://www.gotoper.com/courses/from-bench-to-bedside-paradigm-shifts-in-her2-metastatic-btc-treatment Follow us on social media: • X/Twitter: https://twitter.com/oncbrothers • Instagram: https://www.instagram.com/oncbrothers • Website: https://oncbrothers.com/ Don't forget to like, subscribe, and hit the notification bell for more updates from the Oncology Brothers!
Are you using the best approach for patients with HER2-positive biliary tract cancer (BTC)? Credit available for this activity expires: 4/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002492?ecd=bdc_podcast_libsyn_mscpedu
Featuring perspectives from Dr Mitesh J Borad and Dr Amit Mahipal, including the following topics: Introduction (0:00) Targeted Therapeutic Approaches for Patients with Biliary Tract Cancers (BTCs) — Dr Mahipal (4:59) Integration of Immune Checkpoint Inhibitors into Current BTC Management — Dr Borad (32:16) CME information and select publications
Welcome to the Oncology Brothers podcast! In this episode, Drs. Rohit and Rahul Gosain are joined by Dr. Ghassan Abou-Alfa, a medical oncologist specializing in the hepatobiliary space at Memorial Sloan Kettering. Together, they explored the current treatment landscape of biliary tract cancer, focusing on the advancements in HER2-driven therapies. Key topics discussed included: • The evolution of treatment options for biliary tract cancer, including chemotherapy and immunotherapy. • The significance of genetic testing, including IDH1 mutations, FGFR alterations, and HER2 status. • The role of multidisciplinary collaboration in managing hepatobiliary cancers. • Insights into the latest clinical trials and emerging therapies for HER2-positive biliary tract cancer. Join us as we delve into the complexities of biliary tract cancer and the promising developments in HER2-targeted treatments. Don't forget to check out our next episode, where we will take a deeper dive into the data surrounding HER2 therapies and discuss management strategies for common side effects. YouTube: https://youtu.be/pGiU7JJGNOc Follow us on social media: • X/Twitter: https://twitter.com/oncbrothers • Instagram: https://www.instagram.com/oncbrothers • Website: https://oncbrothers.com/ Subscribe to stay updated on the latest in oncology! #OncologyBrothers #BiliaryTractCancer #HER2 #CancerTreatment #MedicalOncology #CME #Podcast
Dean covers resurfacing an outdoor spa and to prevent it from collapsing. Dean advices a caller on what to do with his plant ledges in his tract home. Dean helps a caller figure out what is causing their whole house water filter from working properly. Plus, Dean talks about restoring stamped concrete and what to avoid. Plus, Eaton Fire phase two clean up and aftermath.
Dean continues with part two of big tract remodeling and recap's part one's important mentions. Dean recaps a bit of part one's show to help set up part two. Dean talks turning windows into sliding doors, as it instantly provides natural lights into a tract home without creating any more holes. Lastly, new garage doors in tract homes and how it could change the visual appeal of a home.
Dean addressed the weaknesses of tract homes, reducing and removing soffits. Dean says to get an inspection camera as it's a helpful tool when planning a remodel. Dean talks about relocating chandeliers and how a fireplace could screw up the living room's improvements (design by demolition). Last, Dean finishes his key elements when it comes to remodeling tract homes.
Dean advices on how to layout a steamed shower and building a wraparound porch on a tiny house. Dean helps a caller on locating California native drought tolerate plants that would go well with either gravel or decomposed granite. Dean says that most tract homes have four different developments and how the developers tend to flip them, change the placement to create an illusion of varies homes for the neighborhood; to make it look full. Plus, he recaps on the craftsmanship, the engineering and the developments of architecture pedigree of tract homes.
Perhaps it's no coincidence that an infusion of spinach leaves has evidently been used since ancient times to treat respiratory symptoms.
© 2020-2025 Ivy Podcast Discovery LLC
